novavax

Delta variant doubles risk of hospitalization; Novavax vaccine highly effective in large trial

• 3 years   ago
• Health

Novavax COVID-19 vaccine more than 90% effective in U.S. trial

• 3 years   ago
• International

Novavax Inc (NVAX.O) on Monday reported late-stage data from its U.S.-based clinical trial showing its vaccine is more than 90% effective against

Novavax to deliver 350 mln COVID-19 vaccine doses to COVAX scheme

• 3 years   ago
• International

Novavax plans to ship COVID-19 vaccines to Europe from late 2021 - EU source

• 3 years   ago
• International

S.Korea says Novavax, Sputnik V COVID-19 vaccines submitted for regulatory approval

• 3 years   ago
• International

South Korea's drug safety ministry said on Thursday that Russia's Sputnik V coronavirus vaccine and a shot developed by Novavax (NVAX.O)

Novavax vaccine 96% effective against original coronavirus, 86% vs British variant in UK trial

• 3 years   ago
• Health

Novavax Inc’s COVID-19 vaccine was 96% effective in preventing cases caused by the original version of the coronavirus in a late-stage trial

Novavax vaccine shows 89% efficacy in UK trials

• 3 years   ago
• Health

A new coronavirus vaccine has been shown to be 89% effective in large-scale UK trials.
The Novavax jab is the first to show in trials

Novavax COVID-19 vaccine news welcomed in South Africa

• 3 years   ago
• Updates

News that the Novavax COVID-19 vaccine has shown about 60% efficacy on HIV-positive patients and that it seems to work against the variant of the

New Covid vaccine shows 89% efficacy in UK trials

• 3 years   ago
• Health

BBC
A new coronavirus vaccine has been shown to be 89.3% effective in large-scale UK trials.

Novavax to Provide 40 Million Doses of Its COVID-19 Vaccine Candidate to Australia

• 3 years   ago
• International

Novavax announced on Wednesday that it has reached an agreement to provide the Australian government with 40 million doses of its COVID-19 vaccine

Coronavirus vaccine: US biotech firm Novavax enters late-stage clinical trials

• 4 years   ago
• Updates

US biotech firm Novavax said it is initiating its final Phase 3 clinical trial for its experimental Covid-19 vaccine.   The trial

Serum Institute's big announcement on coronavirus vaccine, here's when you will get first dose of COVID-19 vaccine

• 4 years   ago
• Updates

Many big companies in the world are engaged in making Vaccine for the Coronavirus pandemic. Adar Poonawalla, chief executive of Serum Institute of

Novavax And Moderna Are Big Covid Vaccine Stock Bets This Year

• 4 years   ago
• Updates

Investors are betting the urgent need to end the Covid-19 pandemic, which has become the biggest healthcare and economic crisis of recent times,